North America miRNA Sequencing and Assay Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America miRNA Sequencing and Assay Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America miRNA Sequencing and Assay Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America miRNA Sequencing and Assay Market Regional Analysis

6.2 North America miRNA Sequencing and Assay Market Revenue 2017-2027 (US$ Million)

6.3 North America miRNA Sequencing and Assay Market Forecast Analysis

7. North America miRNA Sequencing and Assay Market Analysis – by Product

7.1 Library Preparation

7.1.1 Overview
7.1.2 Library Preparation: North America miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Consumables

7.2.1 Overview
7.2.2 Consumables: North America miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America miRNA Sequencing and Assay Market Analysis – by Technology

8.1 Sequencing Synthesis

8.1.1 Overview
8.1.2 Sequencing Synthesis: North America miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Nanopore

8.2.1 Overview
8.2.2 Nanopore: North America miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Ion Semiconductor Sequencing

8.3.1 Overview
8.3.2 Ion Semiconductor Sequencing: North America miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America miRNA Sequencing and Assay Market Analysis – by End User

9.1 Research Institute

9.1.1 Overview
9.1.2 Research Institute: North America miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Academia

9.2.1 Overview
9.2.2 Academia: North America miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 CRO

9.3.1 Overview
9.3.2 CRO : North America miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America miRNA Sequencing and Assay Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America miRNA Sequencing and Assay Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 North America miRNA Sequencing and Assay Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 US: North America miRNA Sequencing and Assay Market Breakdown, by Product
10.2.1.1.2 US: North America miRNA Sequencing and Assay Market Breakdown, by Technology
10.2.1.1.3 US: North America miRNA Sequencing and Assay Market Breakdown, by End User

10.2.1.2 Canada: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Canada: North America miRNA Sequencing and Assay Market Breakdown, by Product
10.2.1.2.2 Canada: North America miRNA Sequencing and Assay Market Breakdown, by Technology
10.2.1.2.3 Canada: North America miRNA Sequencing and Assay Market Breakdown, by End User

10.2.1.3 Mexico : North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Mexico : North America miRNA Sequencing and Assay Market Breakdown, by Product
10.2.1.3.2 Mexico : North America miRNA Sequencing and Assay Market Breakdown, by Technology
10.2.1.3.3 Mexico : North America miRNA Sequencing and Assay Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Illumina, Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 THERMO FISHER SCIENTIFIC INC.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 QIAGEN

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Perkin Elmer, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Takara Bio Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 New England Biolabs

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Norgen Biotek Corp

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 TriLink BioTechnologies Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Lexogen GmbH

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Oxford Nanopore Technologies

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America miRNA Sequencing and Assay Market

Analysis By Product (Library Preparation and Consumables), Technology (Sequencing by Synthesis, Nanopore, and Ion Semiconductor Sequencing), and End User (Research Institute, Academia, and CRO)